These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 28893691)
1. Folate appended cyclodextrins for drug, DNA, and siRNA delivery. Ceborska M Eur J Pharm Biopharm; 2017 Nov; 120():133-145. PubMed ID: 28893691 [TBL] [Abstract][Full Text] [Related]
2. Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles. Erdoğar N; Esendağlı G; Nielsen TT; Şen M; Öner L; Bilensoy E Int J Pharm; 2016 Jul; 509(1-2):375-390. PubMed ID: 27282534 [TBL] [Abstract][Full Text] [Related]
3. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro. Mizusako H; Tagami T; Hattori K; Ozeki T J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848 [TBL] [Abstract][Full Text] [Related]
4. Stimulus-responsive drug/gene delivery system based on polyethylenimine cyclodextrin nanoparticles for potential cancer therapy. Mousazadeh H; Bonabi E; Zarghami N Carbohydr Polym; 2022 Jan; 276():118747. PubMed ID: 34823779 [TBL] [Abstract][Full Text] [Related]
5. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system. Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995 [TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo. Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976 [TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Tumor-Targeting siRNA Delivery Using Folate-PEG-appended Dendrimer (G4)/α-Cyclodextrin Conjugates. Ohyama A; Higashi T; Motoyama K; Arima H Bioconjug Chem; 2016 Mar; 27(3):521-32. PubMed ID: 26715308 [TBL] [Abstract][Full Text] [Related]
9. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo. Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386 [TBL] [Abstract][Full Text] [Related]
10. Ternary complexes of folate-PEG-appended dendrimer (G4)/α-cyclodextrin conjugate, siRNA and low-molecular-weight polysaccharide sacran as a novel tumor-selective siRNA delivery system. Ohyama A; Higashi T; Motoyama K; Arima H Int J Biol Macromol; 2017 Jun; 99():21-28. PubMed ID: 28223132 [TBL] [Abstract][Full Text] [Related]
11. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery. Cao W; Zhou J; Mann A; Wang Y; Zhu L Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug delivery. Caliceti P; Salmaso S; Semenzato A; Carofiglio T; Fornasier R; Fermeglia M; Ferrone M; Pricl S Bioconjug Chem; 2003; 14(5):899-908. PubMed ID: 13129392 [TBL] [Abstract][Full Text] [Related]
13. The application of nanosponges to cancer drug delivery. Trotta F; Dianzani C; Caldera F; Mognetti B; Cavalli R Expert Opin Drug Deliv; 2014 Jun; 11(6):931-41. PubMed ID: 24811423 [TBL] [Abstract][Full Text] [Related]
14. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors. Arima H; Motoyama K; Higashi T Adv Drug Deliv Rev; 2013 Aug; 65(9):1204-14. PubMed ID: 23602906 [TBL] [Abstract][Full Text] [Related]
15. New cyclodextrin bioconjugates for active tumour targeting. Salmaso S; Bersani S; Semenzato A; Caliceti P J Drug Target; 2007 Jul; 15(6):379-90. PubMed ID: 17613656 [TBL] [Abstract][Full Text] [Related]
16. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665 [TBL] [Abstract][Full Text] [Related]
17. Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery. Zhang H; Cai Z; Sun Y; Yu F; Chen Y; Sun B J Biomed Mater Res A; 2012 Sep; 100(9):2441-9. PubMed ID: 22566147 [TBL] [Abstract][Full Text] [Related]
18. Folate acid-Cyclodextrin/Docetaxel induces apoptosis in KB cells via the intrinsic mitochondrial pathway and displays antitumor activity in vivo. Tao J; Xu J; Chen F; Xu B; Gao J; Hu Y Eur J Pharm Sci; 2018 Jan; 111():540-548. PubMed ID: 29097305 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of folate-targeted and PEGylated phytosomes loaded with a mitomycin C-soybean phosphatidyhlcholine complex. Li Y; Wu H; Jia M; Cui F; Lin J; Yang X; Wang Y; Dai L; Hou Z Mol Pharm; 2014 Sep; 11(9):3017-26. PubMed ID: 25054963 [TBL] [Abstract][Full Text] [Related]